High Interest Rates and Deteriorating Creditworthiness: A ‘Double Whammy’… Warning Signs as 23 Companies Face Rating Downgrades
[Mixed Credit Ratings Amid Rising Interest Rates] ②
Three Credit Rating Agencies Issue Negative Outlooks for 22 Companies… 23 Companies Under Review for Downgrade
Pressure on Credit Ratings Due to Weak Business Conditions in the Petrochemical, Construction, and Rechargeable Battery Sectors
Rising Interest Rates and Credit Rating Downgrades… Refinancing Burden Mounts for Non-Invest-Grade Companies
[Edaily Marketin, Reporter KIM YEON-SEO ] As the prolonged period of high interest rates increases the refinancing burden on companies, warning signs of credit rating downgrades have emerged, particularly in sectors experiencing sluggish business conditions, such as petrochemicals, construction, and rechargeable batteries. Concerns are mounting that financing conditions for non-investment-grade companies could deteriorate further as rising interest rates compound worsening earnings. Analysts warn that a vicious cycle—where credit rating downgrades lead to higher borrowing costs—could become a reality.
According to the credit rating industry and Korea Investment & Securities on the 20th, the three major domestic credit rating agencies have assigned a “negative” outlook to 22 companies, excluding duplicates. When companies under review for a downgrade are included, the total number of firms at risk of a credit rating downgrade rises to 23.
Slump in Petrochemicals and Rechargeable Batteries… Pressure on Credit Ratings Mounts
By sector, the deterioration in creditworthiness of petrochemical companies, which have been mired in a prolonged slump, is particularly pronounced. SK GeoCentric (AA-) has received a negative rating outlook from all three credit rating agencies. Hanwha Solutions (AA-) and Hanwha Total Energy (AA-) have also been placed on the negative watch list by multiple rating agencies.
LG Chem (AA+) has also been assigned a negative rating outlook by Korea Ratings and NICE Credit Rating. As the recovery of the petrochemical sector is delayed due to global oversupply and slowing demand, pressure on the credit ratings of major companies appears to be mounting.
The petrochemical sector is struggling to restore profitability as the supply glut caused by China’s expanding production capacity persists. Analysts note that even if market conditions improve temporarily, a sustained rebound in earnings will be difficult unless structural supply pressures are resolved. Companies burdened by accumulated capital expenditures and debt may also face difficulties in maintaining their credit ratings.
Downward pressure is also continuing in the rechargeable battery sector. EcoPro (A-) has been placed on NICE Credit Rating’s negative watch list. This reflects the delay in profitability recovery caused by slowing demand for electric vehicles and the prolonged slump in the rechargeable battery materials market.
SK Siltron (A+) has been classified as under review for downgrade by all three credit rating agencies. Unlike positive or negative outlooks, which indicate the potential for future changes in creditworthiness, a “review for downgrade” suggests a more immediate possibility of a rating adjustment, drawing attention to the actual outcome of the evaluation.
In the construction sector, POSCO E&C (A+) received a negative rating outlook from all three credit rating agencies. The assessment is that the construction market downturn, rising construction costs, and declining profitability are weighing on the company’s creditworthiness. If the recovery of the real estate market is delayed, it is expected to take considerable time for construction companies to improve their financial structures.
A Downgrade of A or BBB Ratings Would
Exacerbate
Refinancing Burdens… Concerns Over Polarization in Funding Sources
could increase. This is because, in a situation where existing corporate bonds must be refinanced at higher interest rates, a widening of credit spreads due to the rating downgrade could compound the problem.
In particular, A- and BBB-rated companies face the risk of a sharp contraction in investment demand should their ratings be downgraded. If an A-rated company is downgraded to BBB, demand may decline due to institutional investors’ criteria, and the likelihood that the company will have to offer higher interest rates when issuing corporate bonds also increases.
A decline in investor sentiment is already clearly evident in the non-investment-grade corporate bond market. Following the successive defaults by JR Global REIT and Joongang Group, issuance of BBB-rated corporate bonds has plummeted, and the gap in financing conditions between investment-grade and non-investment-grade bonds is widening.
Companies facing reduced access to the corporate bond market have no choice but to increase their reliance on alternative funding sources, such as bank loans. However, since bank loans are also affected by rising interest rates and increased credit risk, there are limits to how much they can reduce financing costs. This is why there are concerns that if the industry slump persists, the liquidity burden on non-investment-grade companies could grow even heavier.
Ultimately, in next year’s corporate bond market, the gap in funding rates resulting from changes in credit ratings—in addition to sector-specific earnings—is expected to be a key factor determining companies’ financial soundness. The polarization in funding between companies whose creditworthiness is improving and those exposed to downward pressure is also likely to intensify further.
A credit industry official stated, “In sectors where the slump has persisted—such as petrochemicals—pressure for credit rating downgrades is mounting as earnings recovery is delayed,” adding, “In a high-interest-rate environment, if ratings are lowered, refinancing burdens will increase, particularly for non-investment-grade companies, and polarization in the corporate bond market could intensify.”
As the prolonged period of high interest rates increases the refinancing burden on companies, warning signs of credit rating downgrades have emerged, particularly in sectors experiencing sluggish busi…
On the streets of Hongdae, where morning temperatures had dropped below freezing, one building was bathed entirely in pink. People wearing down jackets with hoods pulled tight lined up along the wall,…
#Aimed Bio Inc.’s antibody-drug conjugate (ADC) “BHV-1530 (AMB302),” which was licensed to U.S.-based Biohaven, has demonstrated initial anticancer efficacy in a Phase 1 clinical trial. Biohaven plans…